PI3K in Stemness Regulation: From Development to Cancer (2019)

First Author: Madsen R

Attributed to: Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.20944/preprints201911.0170.v1

Publication URI: http://dx.doi.org/10.20944/preprints201911.0170.v1

Type: Preprint